![Frank Tegtmeier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank Tegtmeier
Algemeen Directeur bij vasopharm GmbH
Profiel
Frank Tegtmeier is currently the Co-Managing Director & Chief Scientific Officer at vasopharm GmbH since 2001.
Previously, he worked as a Lecturer at Heinrich-Heine-Universität Düsseldorf and as a Principal at Janssen-Cilag GmbH.
Dr. Tegtmeier holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg and Hannover Medical School.
Actieve functies van Frank Tegtmeier
Bedrijven | Functie | Begin |
---|---|---|
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Algemeen Directeur | 01-01-2001 |
Eerdere bekende functies van Frank Tegtmeier
Bedrijven | Functie | Einde |
---|---|---|
Heinrich-Heine-Universität Düsseldorf | Corporate Officer/Principal | - |
Janssen-Cilag GmbH
![]() Janssen-Cilag GmbH Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen-Cilag GmbH is a German pharmaceutical company that focuses on innovative medical research and product development to create a future where disease is no longer a concern. The company is based in Neuss, Germany. The company's Janssen Trial Finder website is designed to inform patients and healthcare professionals about participating in a Janssen clinical trial and to search for clinical trials nearby. Janssen-Cilag was founded in 1959, and Iris Zemzoum has been the CEO of the company since 2012. | Corporate Officer/Principal | - |
Opleiding van Frank Tegtmeier
Hannover Medical School | Doctorate Degree |
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
Janssen-Cilag GmbH
![]() Janssen-Cilag GmbH Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen-Cilag GmbH is a German pharmaceutical company that focuses on innovative medical research and product development to create a future where disease is no longer a concern. The company is based in Neuss, Germany. The company's Janssen Trial Finder website is designed to inform patients and healthcare professionals about participating in a Janssen clinical trial and to search for clinical trials nearby. Janssen-Cilag was founded in 1959, and Iris Zemzoum has been the CEO of the company since 2012. | Health Technology |